AbbVie Partners with Medincell for Development of Long-Acting Injectable Therapies
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has entered into a partnership with France-based...
AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, has entered into a partnership with France-based...